Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/31/2003 | WO2003072036A3 Treatment methods using anti-cd22 antibodies |
12/31/2003 | WO2003066662A3 Protein purification |
12/31/2003 | WO2003064471A3 Gene for peripheral arterial occlusive disease |
12/31/2003 | WO2003055912A3 Secreted proteins |
12/31/2003 | WO2003048208A3 Expression control using variable intergenic sequences |
12/31/2003 | WO2003039486A3 Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies |
12/31/2003 | WO2003037911A3 Antibodies for inhibiting blood coagulation and methods of use thereof |
12/31/2003 | WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them |
12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
12/31/2003 | WO2002077648A3 Pathogenic and commensal vaccine antigens |
12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
12/31/2003 | WO2002055668A3 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7 |
12/31/2003 | WO2002042444A3 Fungal gene cluster associated with pathogenesis |
12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
12/31/2003 | WO2002038766A3 Human tumor necrosis factor receptor |
12/31/2003 | WO2002031198A3 Cancer-linked genes as targets for chemotherapy |
12/31/2003 | WO2001064710A8 Sulfated ccr5 peptides for hiv-1 infection |
12/31/2003 | CN1464908A Multivalent antibodies and uses therefor |
12/31/2003 | CN1464309A Usage of alpha-mannosidase in the immunocyte subgroup sectionalization and method thereof |
12/31/2003 | CN1464068A Human brain tissue specificity molecular marker LRRC4 |
12/31/2003 | CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function |
12/31/2003 | CN1464053A New polypeptide-Glycosyl 12 and polynucleotides for coding same |
12/31/2003 | CN1464052A New polypeptide-human RNA uncoiling enzyme 95 and polynucleotides for coding same |
12/31/2003 | CN1464049A New polypeptide-human sailer transposase 11 and polynucleotides for coding same |
12/31/2003 | CN1463985A Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom |
12/31/2003 | CN1463749A Anti-sphagitis specificity composite IgY and preparation thereof |
12/31/2003 | CN1132939C Coding sequence of pyrophosphate synthetase, its encoded polypeptide and its preparing process |
12/31/2003 | CA2490747A1 Method for generating monoclonal antibodies |
12/31/2003 | CA2490746A1 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation |
12/31/2003 | CA2490423A1 Buffered formulations for concentrating antibodies and methods of use thereof |
12/31/2003 | CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target |
12/31/2003 | CA2490009A1 Serum protein-associated target-specific ligands and identification method therefor |
12/31/2003 | CA2489540A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
12/31/2003 | CA2489057A1 Compositions and methods for apo-b48 and apo-b100 assay |
12/31/2003 | CA2486490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
12/30/2003 | US6670466 Human endogenous retrovirus in breast cancer |
12/30/2003 | US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
12/30/2003 | US6670453 Crosslinking, agglutination, purification |
12/30/2003 | US6670450 Polypeptide that inhibits the differentiation of myoblasts into myotubes as well as the transactivation function of p53, a transcription factor involved in tumor suppression. |
12/30/2003 | US6670321 Prevention and treatment for retinal ischemia and edema |
12/30/2003 | US6670183 88kDa tumorigenic growth factor and antagonists |
12/30/2003 | US6670181 Compositions and methods for treating viral infections |
12/30/2003 | US6670165 Generation preferential hydrolase; obtain sample containing hydrolase, incubate with phosphotransferase, recover hydrolase |
12/30/2003 | US6670164 Isolated human kinase proteins |
12/30/2003 | US6670160 Enzymatic polypeptide; for the diagnosis and detection of mammalian tumors |
12/30/2003 | US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function |
12/30/2003 | US6670136 Peptide for use in the treatment of inflammation defects |
12/30/2003 | US6670135 Assaying the binding of a DCSema polypeptide to a VESPR protein. |
12/30/2003 | US6670134 Identifying modulators of the receptor, especially by measuring the increase or decrease in adenylate cyclase activity. |
12/30/2003 | US6670123 Method for detecting hematopoietic stem cells |
12/30/2003 | US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes |
12/30/2003 | US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes |
12/30/2003 | US6669938 ImmunoConjucates for cancer diagnosis and therapy |
12/30/2003 | US6669937 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs |
12/30/2003 | CA2380690C Human osteoclast-derived cathepsin |
12/30/2003 | CA2215727C Hybrid phthalocyanine derivatives and their uses |
12/30/2003 | CA2163641C Multiple sclerosis virus |
12/25/2003 | WO2003106497A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
12/25/2003 | WO2003106495A2 MONOCLONAL ANTIBODY hPAM4 |
12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
12/25/2003 | US20030236392 Genetic engineering; polypeptide library |
12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
12/25/2003 | US20030236210 Detection and modulation of Slit and roundabount (Robo) mediated angiogenesis and uses thereof |
12/25/2003 | US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer |
12/25/2003 | US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2 |
12/25/2003 | US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
12/25/2003 | US20030235908 Adjusting lymphocyte concentration; closed container; discharging filter |
12/25/2003 | US20030235901 Detoxification using amylase; drug screening analysis |
12/25/2003 | US20030235900 Anticancer agents |
12/25/2003 | US20030235898 Nematode GS-like sequences |
12/25/2003 | US20030235897 Immunological control of beta-amyloid levels in vivo |
12/25/2003 | US20030235891 Method for generating monoclonal antibodies |
12/25/2003 | US20030235880 Genetic engineered nucleic acid |
12/25/2003 | US20030235869 Biological products |
12/25/2003 | US20030235868 Antibodies specific for mucin polypeptide |
12/25/2003 | US20030235861 Multimolecular, two-dimensional lattice or aggregate comprising immobilized cd antigens and monoclonal antibodies for monitor protein binding activity; competetive binding bioassay; treating cancer, allergies and inflammation |
12/25/2003 | US20030235853 Solid phase synthesis; for drug screening |
12/25/2003 | US20030235842 Map |
12/25/2003 | US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
12/25/2003 | US20030235823 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation |
12/25/2003 | US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents |
12/25/2003 | US20030235818 Identifying amino acid sequences which mimic epitopes of target proteins such as shigella toxin, hepatitis viral coat protein and anthrax lethal factor for development of genetic vacines |
12/25/2003 | US20030235815 Synthetic peptides that bind to the hepatitis B virus core and E antigens |
12/25/2003 | US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof |
12/25/2003 | US20030235587 Anticoagulant agents useful in treatment of thrombosis |
12/25/2003 | US20030235586 Can be produced in a transfectoma or in a non-human transgenic animal capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching |
12/25/2003 | US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha |
12/25/2003 | US20030235584 Method for preparing anti-MIF antibodies |
12/25/2003 | US20030235582 Anti-IGF-I receptor antibody |
12/25/2003 | US20030235578 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
12/25/2003 | US20030235556 Combination IL-2/anti-HER2 antibody therapy for cancers characterized by overexpression of the HER2 receptor protein |
12/25/2003 | US20030235555 Antiasthmatics |
12/25/2003 | US20030235533 A nucleic acid sequence that is expressed by human prostate cancer cells, an expressed antigen that elicits antibodies, diagnostic kit comprising a monoclonal antibody is used to detect prostate cancer |
12/24/2003 | WO2003107249A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
12/24/2003 | WO2003107003A1 Positive identification of phospho-proteins using motif-specific, context-independent antibodies coupled with database searching |
12/24/2003 | WO2003106974A2 Diagnosis and treatment of chemoresistant tumors |
12/24/2003 | WO2003106697A2 Method and kit for identifying pseudomonas aeruginosa |
12/24/2003 | WO2003106695A2 Methods and compositions for in vivo clearance of pathogens |
12/24/2003 | WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
12/24/2003 | WO2003106684A2 A method for simultaneous production of multiple proteins; vectors and cells for use therein |